AU2001282800A1 - New strains of lactobacillus paracasei - Google Patents
New strains of lactobacillus paracaseiInfo
- Publication number
- AU2001282800A1 AU2001282800A1 AU2001282800A AU2001282800A AU2001282800A1 AU 2001282800 A1 AU2001282800 A1 AU 2001282800A1 AU 2001282800 A AU2001282800 A AU 2001282800A AU 2001282800 A AU2001282800 A AU 2001282800A AU 2001282800 A1 AU2001282800 A1 AU 2001282800A1
- Authority
- AU
- Australia
- Prior art keywords
- cheese
- strain
- cheeses
- lactobacillus paracasei
- adjunct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
NEW STRAINS OF LACTOBACILLUS PARACASEI
The present invention refers to new strains of Lactobacillus paracasei. which can be used for the manufacture of fermented dairy products, especially probiotic cheese.
BACKGROUND OF THE INVENTION
Swedish cheese is made from pasteurised cows milk which is fermented by a starter culture of lactic acid bacteria.. The acidified milk is curdled by rennet (chymosin) and the coagulated milk is cut and stirred. The mixture of whey and cheese grains is gently heated. The whey is separated and the cheese grains pressed to a cheese which, is salted and ripened; the order of whey separation and pressing depends on the cheese variety. During the ripening a secondary flora of mainly lactic acid bacteria is growing spontaneously.
Swedish hard and semi-hard cheese will during the ripening be dominated by a spontaneously growing secondary icroflora, often referred to as non-starter lactic acid bacteria, NSLAB. This spontaneous flora succeed the added starter culture and grow under the selective conditions of a maturing cheese . NSLAB are thought to enter the dairy plant either with the raw milk after surviving the pasteurisation or with other ingredients used for the cheese making. The NSLAB most commonly found in Swedish and Norwegian cheese belong to the genus Lactobacillus and especially the species Lactobacillus paracasei , see Lindberg, A.-M., et al . , Bacterial flora of Norwegian and Swedish semi-hard cheese after ripening, with special reference to Lactobacillus, Netherlands Milk & Dairy Journal 50 (1996) 563-572. NSLAB start to grow after a few days of ripening and reach levels of about 106 - 107 cfu/g after one month of ripening and this level is maintained for at least five months. Cheddar cheese show the same development of NSLAB dominated by lactobacilli . Examples of species reported from Cheddar are Lactobacillus casei , Lactobacillus plantarum and Lactobacillus brevis, but usually the dominating species are Lactobacillus casei or Lactobacillus paracasei . As the NSLAB is not controlled, it is plausible that some of the variations in cheese quality is due to the variability in the composition of the NSLAB. In order to control the process of ripening and the growth of the spontaneous flora of NSLAB, pure cultures of
strains of for instance Lactobacillus have been used as adjuncts in cheese manu acturing. Said adjuncts in general might have an effect on the aroma and' flavour of the cheese product; an effect which is not predictable but has to be tested by trial and error.
Probiotic microorganisms in dairy products have been the subject for intense research during the last decade. The potential health-promoting effects of dairy products which incorporate probiotic organisms, such as Lactobacillus and Bifidobacterium spp., has stimulated said research. Probiotic bacteria are described as "a live microbial feed supplement which beneficially affects the host animal by improving its microbial balance" which upon digestion in certain numbers exert health benefits, Fuller, R., Probiotics in man and animal, Journal of applied Bacteriology, 66 (1989) 365-378. Desirable traits for selection of functional probiotics are summarised and described by Klaenhammer, T.R., et al., Selection and design of probiotics, International Journal of Food Microbiology 50 (1999) 45-47. The selection criteria are said to fall into four basic categories, that is appropriateness such as nontoxicity, technological suitability such as viability, competiveness that is capability to survive in the gut, performance and functionality. Understanding the mechanisms of how these criteria impact in vivo functionality will present a major challenge in the f ture .
PRIOR ART
Previous studies have demonstrated that bifidobacteria as well as a number of probiotic Lactobacillus strains can survive well in hard cheeses, such as Cheddar cheese and Gouda cheese.
Gomes, A.M., et al . , Incorporation and survival of Bifidobacterium sp . strain Bo and Lactobacillus acidophilus strain Ki in a cheese product, Netherlands Milk & Dairy Journal 49 (1995) 71-95, discloses the manufacture of a probiotic Gouda cheese using a combination of a strain of Bifidobacterium and a strain of L. acidophilus as a starter. It was found that both species survived relatively good, but that the sensory properties were negatively affected.
Dinkar et al., Growth and viability of Bifodobacterium
bifid m in Cheddar cheese, J Dairy Sci 77:2854-2864,1994, discloses the incorporation of Bifidobacterium bifidum into Cheddar. A good viability (107 cfu/g) without negative effects on the cheese quality after 6 months of ripening was obtained if the bacteria were added as an adjunct at a later stage of cheese making, such as milling or salting . This study was followed by a trial were the performance of a number of probiotic Lactobacillus strains, L. salivarius and L . paracasei , were studied in Cheddar over a period of 8 months of ripening; Gardiner et al . , Development of a probiotic Cheddar cheese containing human-derived Lactobacillus paracasei strains, Applied and Environmental Microbiology, 292-2199, June 1998. It was concluded that the probiotic L. paracasei strains were particularly suitable as adjuncts as they grew to high numbers in the cheese and influenced the proteolysis but not the sensory properties.
DESCRIPTION OT THE DRAWINGS
Figure 1 is the image of the REA-profile of the strain Lactobacillus paracasei 8700:2, DSM 13434.
Figure 2 is the image of the REA-profile of the strain Lactobacillus paracasei 02A, DSM 13432.
Figure 3 is a photo of the RAPD-profiles of the two strains L. paracasei 8700:2 and 02A.
DESCRIPTION OF THE INVENTION
The present invention refers to new probiotic strains of Lactobacillus paracasei which can be used as adjuncts in the production of cheese, which strains have advantageous survival properties in cheese as well as the ability to give the cheese a good flavour.
The invention especially refers to a strain of Lactobacillus paracasei which can be used as probiotics in diary products, and which is characterized in surviving the gastrointestinal passage and giving a palatable cheese product when used as an adjunct in the production of cheese.
According to a preferred aspect the invention refers to the strain Lactobacillus paracasei 8700:2, which has been deposited with the DSMZ-Deutsche Sammlung von Mikroorganismen
und Zellkulturen GmbH, Mascheroder Weg lb, 38124 Braunschweig, Germany, on April 10, 2000, and has been given the accession number DSM 13434, or a ariant thereof. Figure 1 shows the REA- profile of this strain, that is the Restriction Endonuclease Analysis profile obtained from the total chromosomal DNA after cutting with the restriction enzymes Hind III (lane C) , Cla I (lane B) and Eco RI (lane A) . STD stand for a size marker, which is a combination of High Molecular Marker (Life Technologies) and DNA Molecular Weight Marker VI (Rouche Molecular Biochemicals, Boehringer Mannheim) .
According to another preferred aspect the invention refers to the strain Lactobacillus paracasei 02A, which has been deposited with the DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg lb, 38124 Braunschweig, Germany, on April 10, 2000, and has been given the accession number DSM 13432, or a variant thereof. Figure 2 shows the REA- profile of this strain, that is the Restriction Endonuclease Analysis profile obtained from the total chromosomal DNA after cutting with the restriction enzymes Hind III (lane C) , Cla I (lane B) and Eco RI (lane A) . STD stands for a size marker, which is a combination of High Molecular Marker (Life Technologies) and DNA Molecular Weight Marker VI (Rouche Molecular Biochemicals, Boehringer Mannheim) .
The REA-analysis was performed according to Johansson et al . , International Journal of Systematic Bacteriology (1995) 10, 670-675.
Figure 3 shows the RAPD-profiles of strain 02A (lane 2) and strain 8700:2 (lane 3). Lanes 1 and 4 are DNA Molecular Weight Marker VI (Rouche Molecular Biochemicals, Boehringer Mannheim) . The RAPD-analysis was performed as. described in Material and methods, below.
The new strains of the invention can be used as a probiotic in any dairy food product, such as fermented dairy products, yogurt and ice-cream, spread, fresh cheese, hard and semi-hard cheeses manufactured with calf-rennet and with a fat content of 5-50%, soft cheese and quarge and quarg based products with a fat content of 0.1-40%, as well as kes.o with or without fermented dressing or live bacteria in the curd.
A preferred use of a strain according to the invention is
as an adjunct in the manufacture of cheese.
The invention also refers to a dairy food product which contains one or more of the new strains of the invention. The content of the probiotic strain in the food product should be 10s-109 cfu/g, preferably above 107.
According to a preferred aspect the invention refers to a hard or semi-hard cheese with improved flavour, which contains the strains Lactobacillus paracasei 8700:2, DSM 13434; or to a hard or semi-hard cheese with improved flavour, which contains the strain Lactobacillus paracasei 02A, DSM 13432.
According to another aspect the invention also refers to a yogurt which contains the strain Lactobacillus paracasei 8700:2, DSM 13434, or Lactobacillus paracasei 02A, DSM 13432, in admixture with conventional yogurt cultures.
EXEMPLIFICATION
15 different Lactobacillus strains of intestinal origin (Lactobacillus rhamnosus 11 strains, Lactobacillus paracasei 3 strains and Lactobacillus plantarum 1 strain), were tested in a screening trial in a cheese model monitoring the ability to grow and survive in cheese and the influence on cheese flavour. The different strains had been obtained from human intestines using the method described in Molin, G., et al . , Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines, Journal of Applied Bacteriology 74 (1993) 314-323.
As a result of this test 4 of the strains were chosen for further studies; the strains are presented in Table 1 below.
Table 1
Screening test of probiotic strains in 30+ round-eyed cheese
This study investigates the performance of three strains of Lactobacillus paracasei and one Lactobacillus plantarum strain, all isolated from human intestinal ucosa, as adjuncts in a round-eyed cheese with at least 30% fat in dry matter. The test strains are presented in Table 1 above .
Cheese manufacture
Cheeses were manufactured in a 400 1 vat, according to a standard protocol, from pasteurised (73°C, 15 s) cow's milk (Skanemejerier, Hδrby, Sweden) . The cheeses manufactured were semi-hard, round-eyed with 30% fat in dry matter. The cheese milk was inoculated with 106 cfu/ml of the test strains. The test strains were added to the milk after (30 min) inoculation with the lactic starter culture, from thawed freezing buffer. Each batch yielded four cheeses of approximately 10 kg, out of which three were ripened at 12°C and one was initially ripened at 16°C for 14 days and thereafter at 12°C. The cheeses were ripened in plastic foil. The cheesemaking was performed in four replicates. Four batches were made each week, three batches with different adjuncts and one control batch, without adjunct. The manufacturing order was randomised for each week. Totally 22 batches were manufactured, 6 control batches and 4 batches with each of the 4 adjunct cultures.
Cheese analysis
Two separate batches produced with different adjuncts and two control batches were sampled after 5 months of ripening, 1 cheese from each batch. The remaining 4 control batches and duplicate batches with different adjuncts were sampled after 6 months of ripening (2 cheeses from each batch ripened at different initial temperatures) . The cheeses were sampled for their sensory properties, microbiological properties and physico-chemical properties.
Microbiological sampling of cheese
A sample of 10 g was aseptically collected from the centre of the cheese and homogenised with 90 ml 2% sodium
citrate solution in a Stomacher (Seward Medical Limited, London SE1 1PP, UK) for 2.5 min. After conventional dilution and plating, total aerobic and anaerobic viable counts were done on Brain Heart Infusion agar (BHI; Difco, Sparks, USA) incubated at 28°C for 4 days. Viable count of lactobacilli were analysed on Rogosa agar (Merck, Darmstadt, Germany) incubated anaerobically at 28°C for 4.days.
Isolation of microorganisms from cheese
Seven colonies were randomly picked from each sample . Two were picked from the total viable counts (BHI agar) and three from the selective viable count of lactobacilli (Rogosa agar) . Countable plates with no less than 20 colonies were used.
Microbiological analysis
REA-analysis
Chromosomal DNAs were prepared for the Restriction Endonuclease Analysis (REA) according to the protocol of Johansson et al . , 1995, see above. The chromosomal DNA was separated from covalently closed circular plasmid DNA (most of the plasmid DNA) by dye buoyant densisty centrifugation in a CsCl gradient with ethidium bromide. Some linear and open circular forms of plasmid DNA may still be present in the preparations, but only cintributing marginally to the final result . The concentration of the chromosomal DNA was monitored in a fluoro eter (Model TKO 100, Hoefer Scientific Instruments, San Fransisco, USA). DNA (0.75 mg) was separately digested at 37°C for 4 h with 10 units Of Hindlll , CLAI or ECORl (Boehringer) . Electrophoresis and scanning of gels was performed as described by Johansson et al . Submerged horizontal 0.9% agarose slab gels in size of 150-235 mm were used. An amount of 0.2 mg of a high molecular weight DNA marker (containing DNA fragments of molecular weights from 8.5 to 48.5 kb (Bethesda Research Laboratories, BRL) together with 0.5 mg of DNA molecular weight marker VI containing DNA fragments of molecular weights from 0.2 to 2.2 kb (Boehringer Mannheim) were used as standards. Gels were run at a constant voltage of 40 V for 18 h at 8.5°C. The buffer was recirculated during the running period. Thereafter the gels were stained for 20 minutes in ethidium
bromide (2 mg/ l) , destined in distilled water, visualized at 302 nm with a UV transluminator (UVP Inc., SanGabriel, USA) and photographed. This way of running the gel electrophoresis gives well-distributed and relatively well-separated bands down to a molecular weight of about 1.8 kb . REA-patterns on photonegatives were scanned into a computer with a flatbed scanner at a resolution of 200 dpi. The gel images were than converted to BioNumerics format (Applied Maths, Kortrijk, Belgium) Normalization and all further analysis of the gels was done in BioNumerics 1.0. The gel traces were anlyzed with Pearson product moment correlation coefficient and the unweighted pair group method by arithmetic averages (UPGMA) . The data from the three cleavages, that is by HIND III, CLA I and Eco RI, were combined for each strain using BioNumerics 1.0.
RAPD-analysis
All isolates were typed by the method of Randomly Amplified Polymorphic DNA, that is RAPD (Quednau et al . , 1998, Current Microbiology, 36, 332-336) . Crude cell extracts were prepared from over night cultures incubated at 28°C in 1 ml BHI for isolates from the BHI agar plates and in 1 ml Lactobacillus carrying medium, LCM, for isolates from the Rogosa agar plates. The cells of pure culture were washed twice in 1 ml sterile Milli-Q® water (Millipore S.A., Molsheim, France), and disrupted in an Eppendorf tube with glass beads, 2 mm in diameter, using an Eppendorf Mixer (5432; Eppendorf, Hamburg, Germany) . The primer used had the sequence 5"*-ACGCGCCCT-3^ with a concentration in the reaction mixture of 15 mM. The RAPD-procedure resulted in a suitable number of distinct bands on the gels for the presently typed lactobacilli, as it previously has been proved to do for Lactobacillus plantarum (Johansson, M.L., et al., Randomly amplified polymorphic DNA (RAPD) for typing of Lactobacillus plantarum strains, Letters in Applied Microbiology, 21 (1995) 155-159) .
The band patterns of the gels were analysed with Pearson product moment correlation coefficient® and the Unweighted Pair Group Method with Arithmetic averages (UPGMA; Romesburg, 1984) by using Gel Compar™ 4.2 (Applied Maths, Kortrijk, Belgium). The computerised cluster analysis of the RAPD-patterns was combined
with a visual comparison.
Sensory assessment
The cheeses were graded after 5 months by 7 graders (6 expert graders and 1 member of the staff at the Department of Food technology, Lund University) , on a hedonic scale (translated into a 0-10 scale after analysis) considering the number of attributes, (quality of: surface, smell, initial texture, secondary texture, flavour and intensity of: smell, flavour, off-flavour) and overall quality. After 6 months the cheeses were graded by 4 expert graders, on a hedonic scale considering surface-, texture-, smell-, flavour- and overall- quality and the intensity of 11 connected attributes . The cheeses were tempered to 16°C and marked with a random 3 digit number and served in a random order.
Results Cheese manufacture
The pH of the cheeses during manufacture were similar in all the test groups . The composition of the cheeses varied as expected between the test groups, due to the difficulties in manufacturing cheese in this scale.
Microbiological analysis of cheese
In cheeses sampled after 5 months of ripening, cheeses manufactured with adjunct had about 1 Lg cfu/g higher viable counts than the reference cheeses. The values are given in the following Table 2.
Table 2. Bacterial viable counts in cheese after 5 months ripening
The isolates from all of the sampled cheeses after 5 months of ripening (10 cheeses, 70 isolates) were classified into 12 different RAPD-types. The isolates from the control cheese were classified into 7 different RAPD-types while the isolates from cheeses manufactured with adjunct 04C were of 5 different RAPD- types and the isolates from cheeses manufactured with adjunct 02A were of 4 different RAPD-types. The isolates from cheeses manufactured with adjuncts 8700:2 and 8589:2 were of 3 different RAPD-types, respectively. All cheeses had isolates of one RAPD- type in common.
All of the used adjunct cultures were found in the corresponding duplicate samples of cheese, after 5 months of ripening. The adjunct cultures 04C, 8589:2 and 02A were reisolated from Lactobacillus-selective agar only (04C: 2 out of 6 isolates; 8589:2: 3 out of 6 isolates; 02A 4 out of 6 isolates) . In one control cheese, one isolate of the same RAPD- type as 04C was found and in the other control cheese, one isolate of the same RAPD-type as 02A was found. Adjunct 8700:2 was reisolated from total count agar (2 out of 8 isolates) and Lactobacillus-selective agar (6 out of 6 isolates) .
In cheeses sampled after 6 months of ripening the total viable counts for all test groups were similar (8,0-8,4 Lg (cfu/g cheese) ) in cheeses ripened at 12°C. In cheeses initially ripened at 16°C the total viable counts were generally lower than in cheeses ripened at 12°C, especially in the control cheeses (7,4-7,5 Lg (cfu/g cheese)). The selective counts of lactobacilli in cheeses ripened at 12°C were generally higher in cheeses manufactured with adjuncts (7,6-7,8 Lg (cfu/g cheese)) than in the control (7,3 Lg (cfu/g cheese)). The selective count of lactobacilli after 6 months of ripening was not influenced by the increased initial ripening temperature.
Sensory assessment
After 5 months of ripening, the control cheeses had the significantly lowest scores for texture (initial and secondary) compared to cheeses manufactured with adjuncts. The surface had significantly lower scores in the control and cheese manufactured with adjunct 8700:2 compared to cheeses manufactured with
adjuncts 8589:2 and 02A. Cheeses manufactured with adjuncts 8700:2 and 02A had significantly higher scores for flavour quality and overall quality compared to the control cheeses. Among the cheeses manufactured with adjunct culture, cheeses manufactured with 8700:2 had the highest score for overall quality and the lowest score for off-flavour intensity. Cheeses manufactured with 02A had the highest scores for flavour quality and intensity. All analysed cheeses recieved very similar scores for the quality and intensity of smell (data not shown) .
In Table 3 below the pH during manufacture, the fat in dry matter and moisture in non-fat solids for one cheese from 2 batches of each test-group (mean ± standard deviation) is shown. The scale for the sensory assessment are 1 = bad quality, low intensity; 10 = good quality, high intensity; mean + standard deviation.
After 6 months of ripening no significant differences were found between cheeses from different test groups. The main trends seen were though, that the increased initial ripening temperature decraesed the texture quality and improved the flavour, especially for cheeses produced with adjuncts.
Table 3
Cheese manufactured with different adjuncts sensory evaluated aft
Controll — 8589:2
PH after pressing 6,01 ± 0,05 6,04 ± 0,04 5,91 ± 0,02 5,
PH after salting 5,39 ± 0,00 5,40 ± 0,00 5,36 ± 0,03 5,
Fat in Dry Matter (%) 34,25 + 0,60 33,65 ± 0,60 32,30 + 0,70 31
Moisture in Non Fat 63,40 ± 0,07 60,15 ± 0,11 58,65 ± 0,74 60 Solids (%)
Surface2 3,42 ± 0,50*a 5,69 ± 1,76 6,72 ± 0,83*b 7,
Initial Texture2 3,98 ± 0,43*c 7,04 ± 0,98*d 6,66 ± 0,88*d 7,
Secondary Texture 3,91 + o,81*e 6,15 ± 0,85*f 5,80 + 0,74*f 6,
Flavour Quality2 4,25 ± 0,86*g 5,39 ± 0,71 5,45 ± 0,67 6,
Flavour Intensity 4, s ± 0,83 5,84 ± 0,84 5,77 ± 0,62 5,
Off-flavour Intensity 3,52 ± 1,383 2,16 ± 0,924 2,70 ± 0,914 2,
_ O—vera—l_l__ Qu_alit_y2 • .— 3,78.—_ ±___ 0,86_ _ 5, .34_—_ ±_ 0,—,65 ,—.5,06 ± 0,74 6, l)No adjunct were added
2) significant differences (P=0.05) between groups indicated with different letters.
3) acid and bitter
4) bitter
Tesiι_Qj JJaa- H-£ϊhio±jj2^^
Also, the ability of the strains to survive intestinal passage when delivered in a cheese was controlled and compared with the spontaneously grown secondary microflora.
Adminis arj2r-atιιy Oral administration
Cheeses inoculated with strains 02A and 8700:2 were selected for the administration study. This selection was based on superior flavour of inoculated cheeses and the test strains ability to grow and survive in the cheese during ripening. The cultures were present in the cheese with more than 107 cfu/g cheese. Volunteers for oral administration were randomly divided into three groups: 1) consumed the control cheese without added adjuncts, 2) consumed cheese inoculated with 8700:2 and 3) consumed cheese inoculated with 02A. Group 1 consisted of 8 volunteers (4 males and 4 females aged 43-51 years) , group 2 consisted of 10 volunteers (5 males and 5 females aged 25-55 years) and group 3 consisted of 11 volunteers (6 males and 5 females aged 26-60 years) . The study was pursued for 5 weeks. During weeks 3 and 4 150 g of the cheese was administered daily, which corresponds to a daily dose of the test strain of >0.5-109 cfu. During the study, persons were forbidden to eat products containing probiotic bacteria or antibiotics . Faecal samples were collected before the start of administration (week 2) , after 2 weeks of administration (week 4) and 1 week after the end of administration (week 5) .
Isolation of micro-organisms from faeces
After conventional dilution and plating of faeces, viable counts of lactobacilli were analysed on Rogosa agar incubated anaerobically at 37°C for 3 days. Three colonies were randomly picked from each sample for typing. Countable plates with no less then 20 colonies were used.
Typing of isolates
All isolates were typed by the method of Randomly Amplified Polymorphic DNA (RAPD; Quednau et al., 1998, supra).
Reisolation
RAPD patterns of isolates from cheeses manufactured with adjuncts was compared with the RAPD pattern of the adjunct and of isolates from the reference cheeses . If the isolates from the cheese with adjunct were of the same RAPD-type as the adjunct, the adjunct was considered to be reisolated.
RAPD-patterns from isolates from faeces from each person was compared with the RAPD-pattern of the adjunct, isolates from cheeses made with this adjunct and isolates from reference cheeses. If isolates of the same RAPD-type as the adjunct were found in faeces after administration of cheese, and not prior to the administration, it was concluded that the adjunct survived intestinal passage. Also, if isolates of the same RAPD-type as the adjunct were found in faeces 1 week after administration of cheese, and not prior to the administration, it was concluded that the adjunct colonised the human bowel.
Statistical Analyses
Analyses of variation and significant differences in viable counts and sensory scores were made by calculating confidence intervals using the t-distribution. A statistical evaluation of the significance of differences in the viable counts in faeces at the three sampling times was performed with the Wilcoxon rank sum test using SPSS 6.0 (SPSS inc., Chicago, USA)
Result of Oral administration
Strain 02A were found in the faeces of 6 out of 11 volunteers, directly after the end of administration. The corresponding figure for strain 8700:2 were 10 out of 10 volunteers. Neither 02A nor 8700:2 were found in faeces of any of the volunteers in these two groups 1 week after ended administration. None of the spontaneously occurring RAPD-types in the control cheeses or in cheeses manufactured with adjunct were found in faeces of the volunteers. Though, isolates of the same RAPD-type as 02A were found in the faeces of 2 volunteers that was administered the control cheese, directly after the end of administration. Also, isolates of the same RAPD-type as 04C were found, 1 week after the end of administration, in the
faeces of 2 volunteers. These 2 volunteers were administered control cheese or cheese manufactured with adjunct 02A. The viable counts of lactobacilli in faeces increased in all groups after the cheese consumption. The increase was statistically significant for the groups eating cheese containing adjunct culture. After the end of administration, the viable counts of lactobacilli decreased for the groups eating cheeses containing adjunct culture, significant for group 3, while it increased for the group eating the control cheese .
The following Table 4 shows the selective count of lactobacilli for the three groups in the study
Table 4
CONCLUSION
The experiments above have shown that the two strains Lactobacillus paracasei 8700:2, DSM 13434, and Lactobacillus paracasei 02A, DSM 13432, perform well as adjunct cultures for manufacturing of cheese and could be reisolated from the cheese after 5 months of ripening. The strains also have a positive effect on the sensory properties, which means that they were able to dominate over the spontaneously growing secondary icroflora.
The administration study has showed that the two strains seem to fulfil the demand of competitiveness as surviving the gastrointestinal passage and therefor fulfil the selection criteria for a potential probiotic strain.
Claims (9)
1. A strain of Lactobacillus paracasei which can be used as probiotics in dairy products, characterized in surviving the gastrointestinal passage and giving a palatable cheese product when used as an adjunct in the production of cheese.
2. A strain according to claim 1, which is Lactobacillus paracasei 8700:2, DSM 13434 or a variant thereof.
3. A strain according to claim 1, which is Lactobacillus paracasei 02A, DSM 13432 or a variant thereof.
4. A strain to any of claims 1-3, for use as an adjunct in the manufacture of cheese.
5. Dairy food product containing a strain according to any of claims 1-3 in an amount of 106-109 cfu/g, preferably >107 cfu/g.
6. Product according to claim 5 being a hard or semi-hard cheese with improved flavour, characterized in containing the strain Lactobacillus paracasei 8700:2, DSM 13434.
7. Product according to claim 5 being a hard or semi-hard cheese with improved flavour, characterized in containing the strain Lactobacillus paracasei 02A, DSM 13432.
8. Product according to claim 5 being a yogurt, characterized in containing the strain Lactobacillus paracasei 8700 : 2 , DSM 13434, in admixture with conventional yogurt cultures .
9. Product according to claim 5 being a yogurt, characterized in containing the strain Lactobacillus paracasei 02A, DSM 13432, in admixture with conventional yogurt cultures.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0003100A SE0003100D0 (en) | 2000-09-01 | 2000-09-01 | New strains |
| SE0003100-5 | 2000-09-01 | ||
| PCT/SE2001/001823 WO2002018542A1 (en) | 2000-09-01 | 2001-08-28 | New strains of lactobacillus paracasei |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001282800A1 true AU2001282800A1 (en) | 2002-06-06 |
| AU2001282800B2 AU2001282800B2 (en) | 2006-06-22 |
Family
ID=20280867
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU8280001A Pending AU8280001A (en) | 2000-09-01 | 2001-08-28 | New strains of lactobacillus paracasei |
| AU2001282800A Expired AU2001282800B2 (en) | 2000-09-01 | 2001-08-28 | New strains of lactobacillus paracasei |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU8280001A Pending AU8280001A (en) | 2000-09-01 | 2001-08-28 | New strains of lactobacillus paracasei |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20040052903A1 (en) |
| EP (1) | EP1313837B1 (en) |
| JP (1) | JP4789396B2 (en) |
| KR (1) | KR100826144B1 (en) |
| CN (1) | CN100467585C (en) |
| AT (1) | ATE312907T1 (en) |
| AU (2) | AU8280001A (en) |
| CA (1) | CA2420977C (en) |
| DE (1) | DE60115919T2 (en) |
| DK (1) | DK1313837T3 (en) |
| ES (1) | ES2250457T3 (en) |
| NO (1) | NO328344B1 (en) |
| NZ (1) | NZ524446A (en) |
| PL (1) | PL204385B1 (en) |
| PT (1) | PT1313837E (en) |
| SE (1) | SE0003100D0 (en) |
| WO (1) | WO2002018542A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2518947A1 (en) * | 2003-03-13 | 2004-11-11 | Kirin Beer Kabushiki Kaisha | Antiallergic composition |
| CN1317385C (en) * | 2003-05-30 | 2007-05-23 | 上海光明乳业股份有限公司 | Cheese lactobacillus Bd-II strain and use for decreasing blood fat |
| KR100517065B1 (en) * | 2003-12-11 | 2005-09-26 | 씨제이 주식회사 | Method for producing lactic acid with high concentration and high yield using lactic acid bacteria |
| WO2007040446A1 (en) * | 2005-10-06 | 2007-04-12 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| CN101384269B (en) * | 2005-10-06 | 2012-11-14 | 普罗比公司 | Use of lactobacillus for treatment of virus infections |
| NL1032678C2 (en) * | 2006-10-13 | 2008-04-15 | Friesland Brands Bv | Method for preparing a semi-hard or hard cheese and cheese thus obtained. |
| EP2420580A1 (en) * | 2010-08-18 | 2012-02-22 | AB-Biotics, S.A. | Probiotic composition for oral health |
| CN103997899B (en) | 2011-06-20 | 2016-04-20 | H.J.亨氏公司 | Probiotic composition and method |
| CA2876963C (en) | 2012-06-18 | 2021-07-06 | H.J. Heinz Company | Gluten-related disorders |
| ES2804615T3 (en) * | 2013-04-03 | 2021-02-08 | Probi Ab | Probiotic strains for use in the treatment or prevention of osteoporosis |
| CA2911496C (en) | 2013-05-10 | 2023-08-22 | H.J. Heinz Company Brands Llc | Probiotics and methods of use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR245869A1 (en) * | 1990-05-11 | 1994-03-30 | Alpine Lace Brands Inc | Low fat, low cholesterol process cheese |
| CA2072159A1 (en) * | 1992-05-19 | 1993-11-20 | Byong H. Lee | Accelerated maturation of cheddar cheese by the addition of live and heat-shocked lactobacilliand neutrase |
| FI102298B1 (en) * | 1995-09-07 | 1998-11-13 | Oulutech Oy | Method for the determination of lactic acid bacterial species and oligonucleotides suitable for the method |
| IT1289984B1 (en) * | 1997-02-27 | 1998-10-19 | Proge Farm Srl | STRAINS OF LACTOBACILLUS USEFUL IN THE TREATMENT OF DISTURBANCES OF THE GASTROINTESTINAL SYSTEM |
| SE510813C2 (en) * | 1997-12-08 | 1999-06-28 | Arla Ekonomisk Foerening | Bacterial strain of the species Lactobacillus Paracasei subsp. paracasei, its composition for use in food, and product containing the strain |
| DE69902260T2 (en) * | 1998-05-29 | 2003-03-20 | Entpr Ie Trd As Bioresearch Ie | PROCESS FOR PRODUCING PROBIOTIC CHEESE |
| BR9912181A (en) | 1998-06-05 | 2001-04-10 | Biotechnology Res & Dev | Biological coating with a protective and curative effect to control post-harvest rot |
| EP1034787A1 (en) * | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| SE0003576D0 (en) * | 2000-10-04 | 2000-10-04 | Probi Ab | New strain |
| JP5186077B2 (en) * | 2000-12-18 | 2013-04-17 | プロバイオヘルス・エルエルシー | Probiotic compound obtained from Lactobacillus casei KE01 strain |
-
2000
- 2000-09-01 SE SE0003100A patent/SE0003100D0/en unknown
-
2001
- 2001-08-28 AU AU8280001A patent/AU8280001A/en active Pending
- 2001-08-28 AU AU2001282800A patent/AU2001282800B2/en not_active Expired
- 2001-08-28 WO PCT/SE2001/001823 patent/WO2002018542A1/en active IP Right Grant
- 2001-08-28 JP JP2002524045A patent/JP4789396B2/en not_active Expired - Lifetime
- 2001-08-28 AT AT01961540T patent/ATE312907T1/en active
- 2001-08-28 US US10/362,373 patent/US20040052903A1/en not_active Abandoned
- 2001-08-28 PL PL362374A patent/PL204385B1/en unknown
- 2001-08-28 CN CNB018179649A patent/CN100467585C/en not_active Expired - Lifetime
- 2001-08-28 NZ NZ524446A patent/NZ524446A/en not_active IP Right Cessation
- 2001-08-28 KR KR1020037003053A patent/KR100826144B1/en active IP Right Grant
- 2001-08-28 PT PT01961540T patent/PT1313837E/en unknown
- 2001-08-28 DE DE60115919T patent/DE60115919T2/en not_active Expired - Lifetime
- 2001-08-28 CA CA2420977A patent/CA2420977C/en not_active Expired - Lifetime
- 2001-08-28 EP EP01961540A patent/EP1313837B1/en not_active Expired - Lifetime
- 2001-08-28 DK DK01961540T patent/DK1313837T3/en active
- 2001-08-28 ES ES01961540T patent/ES2250457T3/en not_active Expired - Lifetime
-
2003
- 2003-02-28 NO NO20030971A patent/NO328344B1/en not_active IP Right Cessation
-
2009
- 2009-02-09 US US12/367,653 patent/US8703472B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8703472B2 (en) | Strains of Lactobacillus paracasei | |
| Stanton et al. | Probiotic cheese | |
| CN102105065A (en) | Improvement of growth of bifidobacteria in fermented milk products | |
| EP1082021A1 (en) | Process for the manufacture of probiotic cheese | |
| Marroki et al. | Lactobacilli isolated from Algerian goat's milk as adjunct culture in dairy products | |
| EP3845069A1 (en) | Sucrose negative streptococcus thermophilus for use in preparation of fermented products | |
| US4870020A (en) | Preparation of compositions including acid-resistant bifidobacteria | |
| AU2001282800A1 (en) | New strains of lactobacillus paracasei | |
| CN111433347B (en) | Streptococcus Thermophilus (ST) cells for the preparation of, for example, maryland cheese | |
| EP1593309B1 (en) | Dairy product with at least one characteristic of a dairy product mixture | |
| WO2001088150A1 (en) | Probiotic lactic acid bacteria, unable to utilize lactose | |
| AU2001292512A1 (en) | New strain of lactobacillus paracasei | |
| Mathara | Studies on lactic acid producing microflora in mursik and kule naoto, traditional fermented milks from Nandi and Masai communities in Kenya | |
| KR102105916B1 (en) | Cottage cheese containing lactobacillus plantarum and ginseng extract and method for producing the same | |
| EP0922391B1 (en) | Composition for curing raw sausage | |
| KR20160097419A (en) | Culture medium of Lactic acid bacteria, fermented milk containing thereof, freeze-dried powder containing thereof and method thereof | |
| WO2023038072A1 (en) | Lactic acid bacterium, lactic acid bacterium starter, fermented milk, method for manufacturing fermented milk, and method for screening lactic acid bacterium | |
| WO2024004139A1 (en) | Fermented milk and production method for fermented milk | |
| Boycheva et al. | Effect of Some Plant Supplements on the Number of Lactic Acid Bacteria in Bulgarian Fermented Milk | |
| Silva | ISOLATION AND CHARACTERIZATION OF MICROORGANISMS FROM DEEKIRI STARTER CULTURES NATIVE TO SRI LANKA. |